Shareholder Payouts Among Large Publicly Traded Health Care Companies

Victor Roy; Victor Amana; Joseph S Ross; Cary P Gross

doi:10.1001/jamainternmed.2024.7687

Shareholder Payouts Among Large Publicly Traded Health Care Companies

JAMA Intern Med. 2025 Apr 1;185(4):466-468. doi: 10.1001/jamainternmed.2024.7687.

Authors

Victor Roy^{1

2}, Victor Amana³, Joseph S Ross^{2

4

5}, Cary P Gross^{2

4

5

6}

Affiliations

¹ Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia.
² National Clinician Scholars Program, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
³ Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut.
⁴ Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.
⁵ Department of Health Policy and Management, Yale School of Public Health, New Haven, Connecticut.
⁶ Associate Editor, JAMA Internal Medicine .

No abstract available

Plain language summary

This cross-sectional study evaluates the implications of shareholder payouts from large health care companies for the goals of health care affordability, quality, and equity.

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States